Us Physicalrapy Stock Beta
| USPH Stock | USD 98.02 0.19 0.19% |
US Physicalrapy fundamentals help investors to digest information that contributes to US Physicalrapy's financial success or failures. It also enables traders to predict the movement of USPH Stock. The fundamental analysis module provides a way to measure US Physicalrapy's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to US Physicalrapy stock.
USPH | Beta |
US Physicalrapy Company Beta Analysis
US Physicalrapy's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current US Physicalrapy Beta | 1.39 |
Most of US Physicalrapy's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, US Physicalrapy is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
USPH Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for US Physicalrapy is extremely important. It helps to project a fair market value of USPH Stock properly, considering its historical fundamentals such as Beta. Since US Physicalrapy's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of US Physicalrapy's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of US Physicalrapy's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, US Physicalrapy has a Beta of 1.389. This is 61.51% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
USPH Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses US Physicalrapy's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of US Physicalrapy could also be used in its relative valuation, which is a method of valuing US Physicalrapy by comparing valuation metrics of similar companies.US Physicalrapy is currently under evaluation in beta category among its peers.
US Physicalrapy ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, US Physicalrapy's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to US Physicalrapy's managers, analysts, and investors.Environmental | Governance | Social |
US Physicalrapy Institutional Holders
Institutional Holdings refers to the ownership stake in US Physicalrapy that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of US Physicalrapy's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing US Physicalrapy's value.| Shares | Geode Capital Management, Llc | 2024-09-30 | 343.1 K | Riverbridge Partners Llc | 2024-09-30 | 336.1 K | Gw&k Investment Management, Llc | 2024-09-30 | 320 K | Envestnet Asset Management Inc | 2024-09-30 | 249.6 K | Northern Trust Corp | 2024-09-30 | 229.8 K | Fred Alger Management, Llc | 2024-09-30 | 172.3 K | Fmr Inc | 2024-09-30 | 164.5 K | Bank Of New York Mellon Corp | 2024-06-30 | 157.1 K | Bank Of America Corp | 2024-06-30 | 150.7 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 2.4 M | Blackrock Inc | 2024-06-30 | 2.3 M |
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, US Physicalrapy will likely underperform.
USPH Fundamentals
| Return On Equity | 0.0475 | ||||
| Return On Asset | 0.0424 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 1.61 B | ||||
| Shares Outstanding | 15.1 M | ||||
| Shares Owned By Insiders | 1.58 % | ||||
| Shares Owned By Institutions | 98.42 % | ||||
| Number Of Shares Shorted | 597.87 K | ||||
| Price To Earning | 34.35 X | ||||
| Price To Book | 3.06 X | ||||
| Price To Sales | 2.31 X | ||||
| Revenue | 604.8 M | ||||
| Gross Profit | 112.02 M | ||||
| EBITDA | 74.37 M | ||||
| Net Income | 37.22 M | ||||
| Cash And Equivalents | 48.57 M | ||||
| Cash Per Share | 3.73 X | ||||
| Total Debt | 258.59 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 1.43 X | ||||
| Book Value Per Share | 32.02 X | ||||
| Cash Flow From Operations | 81.98 M | ||||
| Short Ratio | 6.03 X | ||||
| Earnings Per Share | 0.88 X | ||||
| Price To Earnings To Growth | 3.88 X | ||||
| Target Price | 107.4 | ||||
| Number Of Employees | 3.9 K | ||||
| Beta | 1.39 | ||||
| Market Capitalization | 1.48 B | ||||
| Total Asset | 997.24 M | ||||
| Retained Earnings | 223.77 M | ||||
| Working Capital | 131.19 M | ||||
| Current Asset | 60.18 M | ||||
| Current Liabilities | 19.01 M | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.01 % | ||||
| Net Asset | 997.24 M | ||||
| Last Dividend Paid | 1.75 |
About US Physicalrapy Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze US Physicalrapy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of US Physicalrapy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of US Physicalrapy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:Check out US Physicalrapy Piotroski F Score and US Physicalrapy Altman Z Score analysis. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Dividend Share 1.75 | Earnings Share 0.88 | Revenue Per Share 42.489 | Quarterly Revenue Growth 0.12 |
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.